Merck

Smaller Biopharma M&A on Upswing, Deals Expected to Continue Through 2024
BioSpace
Fri, 05/31/24 - 10:59 am
M&A
Merck
EyeBio
JNJ
Numab Therapeutics
Asahi Kasei
Calliditas Therapeutics
Merck’s potential $3B EyeBio acquisition puts drugmaker back in ophthalmology
BioSpace
Wed, 05/29/24 - 11:54 am
Merck
EyeBio
ophthalmology
M&A
How Merck for Mothers reached 30M women through maternal health programs
Medical Marketing and Media
Mon, 05/20/24 - 05:48 pm
Merck
maternal health
Women's Health
pharma marketing
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Big Pharma
Eli Lilly
Mounjaro
Novo Nordisk
Wegovy
JNJ
Tecvayli
Merck
Vaxneuvance
AbbVie
Qulipta
AstraZeneca
Saphnelo
Novartis
Leqvio
Roche
Genentech
Vabysmo
Amgen
Evenity
Pfizer
Vyndaqel
Merck stops testing combo drug for skin cancer as more patients discontinue
Reuters
Mon, 05/13/24 - 11:14 am
Merck
skin cancer
clinical trials
melanoma
vibostolimab
anti-TIGIT
The Enhertu effect: Daiichi’s plan to build on the success of its crown jewel
Pharma Voice
Fri, 05/10/24 - 11:12 am
Daiichi Sankyo
Enhertu
oncology
Merck
Keytruda strikes out again in endometrial cancer with phase III flop
BioSpace
Thu, 05/9/24 - 11:49 am
Merck
Keytruda
clinical trials
endometrial cancer
How mRNA vaccines could be personalized cancer cures
Axios
Tue, 05/7/24 - 10:59 am
MRNA
vaccines
cancer
personalized medicine
oncology
IO Biotech
Merck
BioNTech
As rival Merck monopolizes BCG supply, ImmunityBio taps Serum Institute for new combo's manufacturing
Fierce Pharma
Mon, 05/6/24 - 11:30 am
Merck
ImmunityBio
BCG
vaccines
bladder cancer
Merck reports data from Phase III gastric cancer treatment trial
Clinical Trials Arena
Thu, 05/2/24 - 11:23 am
Merck
Keytruda
gastric cancer
clinical trials
Pfizer takes top spot in docs' vaccine ranking by 'huge margin'
Fierce Pharma
Wed, 05/1/24 - 09:35 am
physicians
vaccines
Pfizer
Merck
GSK
Moderna Therapeutics
On doorstep of approval, Merck compares V116 pneumococcal vaccine to 1983 warhorse Pneumovax 23
Fierce Biotech
Mon, 04/29/24 - 10:50 pm
Merck
vaccines
V116
pneumococcal disease
Pfizer
Merck Gets Q1 Beat as Sales of Cancer Blockbuster Keytruda Jump 20%
BioSpace
Thu, 04/25/24 - 11:41 am
Merck
earnings
Keytruda
AstraZeneca’s Lynparza to remain dominant in PARP inhibitors market with $4 billion in sales by 2027
Biopharma Reporter
Thu, 04/25/24 - 11:36 am
AstraZeneca
PARP inhibitors
Merck
Lynparza
ovarian cancer
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
Fierce Biotech
Thu, 04/18/24 - 11:11 am
M&A
biotech
AstraZeneca
Merck
Gracell
Harpoon Therapeutics
Merck Paid $208 Million to Stop Its Drugs From Working
Motley Fool
Sun, 04/14/24 - 01:27 pm
Merck
M&A
Abceutics
antibody-drug conjugate
With 9% pay hike, Merck CEO Robert Davis entered $20M compensation club in 2023
Fierce Pharma
Sun, 04/14/24 - 01:20 pm
Merck
Pharma CEOs
Robert Davis
executive compensation
AACR: Merck, Kelun’s Anti-TROP2 ADC Shows Early Promise in Gastric Cancer
BioSpace
Wed, 04/10/24 - 09:59 am
Merck
Kelun-Biotech
SKB264
gastric cancer
antibody-drug conjugate
clinical trials
AACR
Moderna jumps as vaccine shows benefit in head and neck cancer in early study
Reuters
Tue, 04/9/24 - 05:43 pm
Moderna Therapeutics
Merck
clinical trials
vaccines
head and neck cancer
Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS
BioSpace
Fri, 04/5/24 - 11:42 am
Merck
clinical trials
KRAS inhibitors
MK-1084
non-small lung cancer

Pages